MyAverix Finance
F · Healthcare
VISTIN PHARMA ASA NK 1 (VP4)
Drug Manufacturers - Specialty & Generic
VISTIN PHARMA ASA NK 1 (VP4) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VP4
VISTIN PHARMA ASA NK 1 (VP4) — FAQ
What is VP4's P/E ratio?
The price-to-earnings (P/E) ratio for VISTIN PHARMA ASA NK 1 (VP4) is 18.00 (data as of 2026-05-21).
Does VISTIN PHARMA ASA NK 1 pay a dividend?
Dividend yield is not available in the current snapshot for VISTIN PHARMA ASA NK 1 (VP4). Check the MyAverix Finance app for the latest dividend data.
What sector is VISTIN PHARMA ASA NK 1 in?
VISTIN PHARMA ASA NK 1 (VP4) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is VP4 listed on?
VP4 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.